NOTCH4 and neoplasm: The ability of E7011 to reduce vessel perfusion was observed at all dosages tested, down to 1 mg/kg, demonstrating that Notch4 blockade efficiently disrupts tumor vessel function (Supplementary Fig. S4C–S4E).